Results 81 to 90 of about 12,212 (162)

Comparative Effects of Angiotensin Receptor Blockers on Blood Pressure and Serum Urate in Patients With Hypertension and Hyperuricaemia: A Systematic Review and Network Meta‐Analysis

open access: yesMedicine Bulletin, Volume 2, Issue 4, Page 459-475, September 2026.
Allisartan ranked best for serum urate reduction and showed favourable blood pressure control, whereas losartan also performed well overall. These rankings may inform ARB selection but should be interpreted cautiously because of inconsistency, heterogeneity and sparse direct evidence.
Xuanyao Li   +5 more
wiley   +1 more source

Telmisartan and cardioprotection

open access: yes, 2011
Philippe R Akhrass, Samy I McFarlaneState University of New York, Downstate Medical Center, Brooklyn, NY, USAAbstract: Cardiovascular risk reduction has been the target of several large clinical trials in the last decade.
McFarlane S
core  

The vasodilatory action of telmisartan on isolated mesenteric artery rings from rats [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2015
Objective(s): Angiotensin Ⅱ type 1 receptor blockers (ARBs) represent one of the widely used antihypertensive agents. In addition to anti-hypertension effect, some ARBs also show other molecular effects such as activating peroxisome proliferator ...
Xiao-ping Chen, Li-ren Qian
doaj  

Magnetic Nanomedicine for Cancer: Mechanisms, Modalities, and Translation

open access: yesNano Select, Volume 7, Issue 9, September 2026.
At the convergence of nanotechnology, precision oncology and intelligent therapeutics, magnetic nanoparticles (MNPs) are redefining how cancer is detected, targeted and treated. This review critically examines the mechanisms enabling their integration in imaging, targeted drug delivery and magnetic hyperthermia, while exploring how intelligent design ...
Shivani Kadam   +10 more
wiley   +1 more source

Telmisartan in hypertensive treatment — practicalities [PDF]

open access: yes, 2012
Blokowanie układu renina–angiotensyna–aldosteronodgrywa kluczową rolę leczeniu nadciśnienia tętniczegoi zapobieganiu jego narządowym powikłaniom.Telmisartan jest antagonistą receptora angiotensynyII, wykazującym korzystne, szczególne ...
Widecka, Krystyna
core  

Telmisartan Self-Nanoemulsifying Drug Delivery System, Compared With Standard Telmisartan, More Effectively Improves Hepatic Fibrosis in Rats

open access: yesDose-Response, 2020
Background: This study was designed to examine effects of telmisartan; an angiotensin receptor blocker; self-nanoemulsifying drug delivery system (SNEDDS) in reversing already-established hepatic fibrosis. Method: Forty rats were given thioacetamide (200
Hussam Murad   +3 more
doaj   +1 more source

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble

open access: yesPortal Hypertension &Cirrhosis, Volume 5, Issue 3, Page 269-282, September 2026.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) and intrapancreatic fat deposition (IPFD) are both common manifestations of ectopic fat accumulation. Although they share multiple risk factors, they also show notable differences in pathological features, standardization of diagnosis, and research maturity.
Yuying Chen   +5 more
wiley   +1 more source

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension

open access: yes, 2012
Yuji Shimizu,1,4 Fumiyasu Yamasaki,4 Takashi Furuno,1,4 Toru Kubo,1 Takayuki Sato,3,4 Yoshinori Doi,1 Tetsuro Sugiura21Medicine and Geriatrics, 2Clinical Laboratory, 3Cardiovascular Control, Kochi Medical, School, Nankoku, Japan; 4Section of Cardiology ...
Kubo T   +6 more
core  

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

open access: yes, 2008
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular events, but are not tolerated by about 20% of patients. We therefore assessed whether the angiotensin-receptor blocker telmisartan would be effective in patients ...
Teo, K   +50 more
core   +1 more source

Telmisartan - Killing two birds with one stone

open access: yes, 2004
In theory+ a drug that inhibits the renin-angiotensin system in order to lower blood pressure and acts as a PPARγ agonist to increase insulin sensitivity, could be very useful in the treatment of coexisting Type 2 diabetes and hypertension.
Doggrell, Sheila A.
core   +1 more source

Home - About - Disclaimer - Privacy